$63.02
-0.43-0.68%
At close: -
$63.02
0.000.00%
After Hours: Feb 21, 4:02 PM EDT
Haemonetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Haemonetics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2025-02-06 | $1.19 | $1.17 | 1.71 % |
Q2 | 2024-11-07 | $1.12 | $1.07 | 4.67 % |
Q1 | 2024-08-08 | $1.02 | $1.00 | 2.00 % |
Q4 | 2024-05-09 | $0.90 | $0.89 | 1.12 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2025-02-06 | $348.54M | $352.88M | -1.23 % |
Q2 | 2024-11-07 | $345.51M | $342.65M | 0.83 % |
Q1 | 2024-08-08 | $336.17M | $335.38M | 0.24 % |
Q4 | 2024-05-09 | $343.29M | $329.11M | 4.31 % |
Haemonetics (HAE) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 6, 2025 for Q3.
The Actual EPS was $1.19, which beat the estimate of $1.17.
The Actual Revenue was $348.5M, which missed the estimate of $352.9M.
Browse earnings estimates, EPS, and revenue on all stocks.